Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.

Source:http://linkedlifedata.com/resource/pubmed/id/15649305

Download in:

View as

General Info

PMID
15649305